Cargando…

A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infection

PURPOSE: Hepatitis B viral markers may be useful for predicting outcomes such as liver-related deaths or development of hepatocellular carcinoma. We determined the frequency of these markers in different clinical stages of chronic hepatitis B infection. METHODS: We compared baseline hepatitis B vira...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tong, Myron John, Hsu, Leeyen, Hsien, Carlos, Kao, Jia-Horng, Durazo, Francisco Antonio, Saab, Sammy, Blatt, Lawrence Mitchell
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2010
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2896649/ https://www.ncbi.nlm.nih.gov/pubmed/20827410 http://dx.doi.org/10.1007/s12072-010-9179-1

Ejemplares similares

Basal core promoter T1762/A1764 and precore A1896 gene mutations in hepatitis B surface antigen-positive hepatocellular carcinoma: a comparison with chronic carriers
por: Tong, Myron J, et al.
Publicado: (2007)

Evaluation of the impact of rehospitalization in the management of hepatic encephalopathy
por: Saab, Sammy
Publicado: (2015)

Molecular Mechanism and Treatment of Viral Hepatitis-Related Liver Fibrosis
por: Su, Tung-Hung, et al.
Publicado: (2014)

JAK Inhibitors: Treatment Efficacy and Safety Profile in Patients with Psoriasis
por: Hsu, Leeyen, et al.
Publicado: (2014)

Risk of Cardiovascular Events in Patients with Primary Biliary Cholangitis - Systematic Review
por: Suraweera, Duminda, et al.
Publicado: (2018)

Persistent Hepatitis B Viral Replication in a FVB/N Mouse Model: Impact of Host and Viral Factors
por: Chen, Shih-Hui, et al.
Publicado: (2012)

Elimination of Hepatitis C in Liver Transplant Recipients
por: Saab, Sammy, et al.
Publicado: (2018)

Curing Hepatitis C in Liver Transplant Recipients Is Associated with Changes in Immunosuppressant Use
por: Saab, Sammy, et al.
Publicado: (2016)

Progress towards elimination goals for viral hepatitis
por: Cox, Andrea L., et al.
Publicado: (2020)

Management of Hepatitis C Antiviral Therapy Adverse Effects
por: Sung, Hubert, et al.
Publicado: (2010)

Pan-genotypic direct-acting antivirals for patients with hepatitis C virus infection and chronic kidney disease stage 4 or 5
por: Liu, Chen-Hua, et al.
Publicado: (2022)

Evaluation and Management of Hepatic Encephalopathy: Current Status and Future Directions
por: Suraweera, Duminda, et al.
Publicado: (2016)

Sociodemographic and clinical characteristics of persons who experienced spontaneous hepatitis C viral clearance
por: Kimble, Mabel Michille, et al.
Publicado: (2019)

Hepatic Encephalopathy-Related Hospitalizations in Cirrhosis: Transition of Care and Closing the Revolving Door
por: Frenette, Catherine T., et al.
Publicado: (2021)

Markers of Inflammation and Fibrosis in Alcoholic Hepatitis and Viral Hepatitis C
por: Neuman, Manuela G., et al.
Publicado: (2012)

Molecular Epidemiology of Hepatitis B Virus
por: Kao, Jia-Horng
Publicado: (2011)

Evaluation of the Cost-Effectiveness of Entecavir Versus Lamivudine in Hepatitis BeAg-Positive Chronic Hepatitis B Patients
por: Yuan, Yong, et al.
Publicado: (2008)

High Serum Lipopolysaccharide-Binding Protein Level in Chronic Hepatitis C Viral Infection Is Reduced by Anti-Viral Treatments
por: Nien, Hsiao-Ching, et al.
Publicado: (2017)

Direct comparison of biopsy techniques for hepatic malignancies
por: Huang, Shang-Chin, et al.
Publicado: (2021)

Spotlight on grazoprevir–elbasvir once-daily combination and its potential in the treatment of hepatitis C
por: Suraweera, Duminda, et al.
Publicado: (2016)

Noninvasive Diagnosis of Hepatic Fibrosis in Hemodialysis Patients with Hepatitis C Virus Infection
por: Liu, Chen-Hua, et al.
Publicado: (2022)

Limited Knowledge of Acetaminophen in Patients with Liver Disease
por: Saab, Sammy, et al.
Publicado: (2016)

Safety considerations for withdrawal of nucleos(t)ide analogues in patients with chronic hepatitis B: First, do no harm
por: Hsu, Yao-Chun, et al.
Publicado: (2023)

The Impact of Renal Function on Hepatic Encephalopathy Following TIPS Placement for Refractory Ascites
por: Zhao, Matthew, et al.
Publicado: (2023)

Staging Fibrosis in Chronic Viral Hepatitis
por: Cardoso, Ana Carolina, et al.
Publicado: (2022)

Elimination of Hepatitis B: Is It a Mission Possible?
por: Tseng, Tai-Chung, et al.
Publicado: (2017)

New perspectives of biomarkers for the management of chronic hepatitis B
por: Lin, Chih-Lin, et al.
Publicado: (2016)

Transjugular Liver Biopsy: Safe Even in Patients With Severe Coagulopathies and Multiple Biopsies
por: Sue, Megan J., et al.
Publicado: (2019)

Acute hepatitis C virus infection: clinical update and remaining challenges
por: Liu, Chen-Hua, et al.
Publicado: (2023)

Hepatitis C Screening: Barriers to Linkage to Care
por: Saab, Sammy, et al.
Publicado: (2019)

Effectiveness of Ledipasvir/Sofosbuvir with/without Ribavarin in Liver Transplant Recipients with Hepatitis C
por: Saab, Sammy, et al.
Publicado: (2017)

Long‐term survival after surveillance and treatment in patients with chronic viral hepatitis and hepatocellular carcinoma
por: Tong, Myron J., et al.
Publicado: (2017)

Development of hepatocellular carcinoma in treated and untreated patients with chronic hepatitis B virus infection
por: Lin, Chih-Lin, et al.
Publicado: (2023)

History of Hepatic Encephalopathy Is Not a Contraindication to Transjugular Intrahepatic Portosystemic Shunt Placement for Refractory Ascites
por: Saab, Sammy, et al.
Publicado: (2021)

Nanomedicines in the treatment of hepatitis C virus infection in Asian patients: optimizing use of peginterferon alfa
por: Liu, Chen-Hua, et al.
Publicado: (2014)

Persistence of hepatitis B virus covalently closed circular DNA in hepatocytes: molecular mechanisms and clinical significance
por: Yang, Hung-Chih, et al.
Publicado: (2014)

Association of SCARB1 Gene Polymorphisms with Virological Response in Chronic Hepatitis C Patients Receiving Pegylated Interferon plus Ribavirin Therapy
por: Hsu, Ching-Sheng, et al.
Publicado: (2016)

Autoimmune Hepatitis-Like Syndrome Following COVID-19 Vaccination: A Systematic Review of the Literature
por: Chow, Kenneth W., et al.
Publicado: (2022)

Tu1257: AUTOIMMUNE HEPATITIS FOLLOWING COVID-19 VACCINATION: A SYSTEMATIC REVIEW OF THE LITERATURE
por: Chow, Kenneth W., et al.
Publicado: (2022)

Three heads are better than two: Hepatitis B core-related antigen as a new predictor of hepatitis B virus-related hepatocellular carcinoma
por: Wu, Jer-Wei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_euut6clts1i2k0f8789pckct5b